|
1
|
Spivak JL: Polycythemia Vera. Curr Treat
Options Oncol. 19:122018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Landolfi R, Di Gennaro L, Barbui T, De
Stefano V, Finazzi G, Marfisi R, Tognoni G and Marchioli R;
European Collaboration on Low-Dose Aspirin in Polycythemia Vera
(ECLAP), : Leukocytosis as a major thrombotic risk factor in
patients with polycythemia vera. Blood. 109:2446–2452. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lim Y, Lee JO, Kim SH, Kim JW, Kim YJ, Lee
KW, Lee JS and Bang SM: Prediction of thrombotic and hemorrhagic
events during polycythemia vera or essential thrombocythemia based
on leukocyte burden. Thromb Res. 135:846–851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marchioli R, Finazzi G, Specchia G,
Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A,
Latagliata R, et al: Cardiovascular events and intensity of
treatment in polycythemia vera. N Engl J Med. 368:22–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Falanga A and Marchetti M: Thrombotic
disease in the myeloproliferative neoplasms. Hematology Am Soc
Hematol Educ Program. 2012:571–581. 2012.PubMed/NCBI
|
|
6
|
Zhang H, Sun L, Tang Y, Wang M and Wu J:
Effects of Naomaitai Capsule on cerebral blood flow and apoptosis
of hippocampus neuron in rats with vascular dementia induced by
chronic forebrain ischemia. J Int Neurol Neurosurgery. 36:290–293.
2009.
|
|
7
|
Arboix A, Besses C, Massons J and Titus F:
Cerebral infarction as the first manifestation of polycythemia
vera. Med Clin (Barc). 101:398–399. 1993.(In Spanish). PubMed/NCBI
|
|
8
|
Yazdi R and Côté C: Watershed infarction
in a case of polycythemia vera. Clin Nucl Med. 11:665–666. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xin CH, Xu JQ, Sui JR and Wang XL:
Analysis on 71 patients with polycythemia vera. Zhongguo Shi Yan
Xue Ye Xue Za Zhi. 20:667–670. 2012.PubMed/NCBI
|
|
10
|
Zou JM, Pan ZJ and Wang SL:
Pharmacodynamic and toxicologic research on nao mai kang capsule.
China J Traditional Chin Med Pharm. 18:408–413. 2003.
|
|
11
|
Zhang HN, Sun L, Tang YY, Wang MY and Wu
J: Effects of Naomaitai Capsule on cerebral blood flow and
apoptosis of hippocampus neuron in rats with vascular dementia
induced by chronic forebrain ischemia. J Int Neurol Neurosurgery.
36:290–293. 2009.
|
|
12
|
Elliott MA and Tefferi A: Thrombosis and
haemorrhage in polycythaemia vera and essential thrombocythaemia.
Br J Haematol. 128:275–290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kander EM, Raza S, Zhou Z, Gao J, Zakarija
A, McMahon BJ and Stein BL: Bleeding complications in BCR-ABL
negative myeloproliferative neoplasms: Prevalence, type, and risk
factors in a single-center cohort. Int J Hematol. 102:587–593.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barbui T, Carobbio A, Rumi E, Finazzi G,
Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B,
Pieri L, et al: In contemporary patients with polycythemia vera,
rates of thrombosis and risk factors delineate a new clinical
epidemiology. Blood. 124:3021–3023. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marchioli R, Finazzi G, Landolfi R, Kutti
J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G and
Barbui T: Vascular and neoplastic risk in a large cohort of
patients with polycythemia vera. J Clin Oncol. 23:2224–2232. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Landolfi R, Cipriani MC and Novarese L:
Thrombosis and bleeding in polycythemia vera and essential
thrombocythemia: Pathogenetic mechanisms and prevention. Best Pract
Res Clin Haematol. 19:617–633. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tefferi A: Polycythemia vera and essential
thrombocythemia: 2012 update on diagnosis, risk stratification, and
management. Am J Hematol. 87:285–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cerquozzi S, Barraco D, Lasho T, Finke C,
Hanson CA, Ketterling RP, Pardanani A, Gangat N and Tefferi A: Risk
factors for arterial versus venous thrombosis in polycythemia vera:
A single center experience in 587 patients. Blood Cancer J.
7:6622017. View Article : Google Scholar : PubMed/NCBI
|
